Article

Prevalence and characteristics of autistic spectrum disorders in the ALSPAC cohort

Developmental Medicine & Child Neurology (Impact Factor: 2.68). 08/2008; 50(9):672 - 677. DOI: 10.1111/j.1469-8749.2008.03042.x

ABSTRACT The aim of this study was to determine the prevalence of autistic spectrum disorder (ASD) within a large representative population sample: the Avon Longitudinal Study of Parents and Children (ALSPAC). Cases of ASD were identified from the clinical notes of children in the ALSPAC with a suspected developmental disorder and from the Pupil Level Annual Schools Census (PLASC) for England in 2003. Seventy-one cases of ASD diagnosed after a multidisciplinary assessment were identified from health records. There were an additional 15 cases from PLASC data in which ASD was mentioned as a principal difficulty, thus giving a total of 86 children diagnosed by the age of 11 years. Prevalence of ASD per 10 000 population at 11 years was 51.1 for those with a multi-professional diagnosis, and 61.9 if cases from education were included, made up of 21.6 for childhood autism, 10.8 for atypical autism, 16.6 for Asperger syndrome, and 13.0 for unspecified ASD. The male:female ratio was 6.8:1. Median age at diagnosis ranged from 45 months in childhood autism to 116 months in Asperger syndrome. A comorbid developmental disorder was recorded in 33.8% of cases, including learning disability† in 14.7%, epilepsy in 10.3%, and mixed developmental disorder in 4.4%. We conclude that the prevalence of ASD diagnosed at 11 years in a UK representative population-based sample is at least 51.1/10 000.

0 Bookmarks
 · 
55 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Autism is a neurodevelopmental disability that may affect nutritional management of children with autism. This study aimed to compare the nutritional status of children with autism with that of typically developing children (aged 4–6 years) in China. Nutritional status was assessed by means of nutritional data, anthropometric data, biochemical assessment, physical examination for nutrient deficiencies and providing a questionnaire to parents. A total of fifty-three children with autism and fifty-three typically developing children were enrolled in this study. The parents were asked to complete the questionnaire regarding the eating behaviour and gastrointestinal symptoms of their children. They were also asked to provide a 3 d food diary. Children with autism exhibited several abnormalities in terms of eating behaviour and gastrointestinal symptoms. The levels of vitamins A and B6, Zn and Ca intakes were <80 % of the dietary reference intakes in both groups. In addition, the proportions of vitamin C and Ca intake deficiencies in the autism group were significantly higher than those in the control group. Serum Zn level was less than the normal reference range in both the groups. Serum Ca, vitamin A and folate levels in children with autism were significantly lower when compared with children without autism. According to the anthropometric data, the mean BMI, weight-for-height Z-score (Z WH) and BMI for age Z-score (Z BMIA) of children with autism were significantly higher than those of the typically developing children. Thus, nutritional inadequacies were observed in children with autism and typically developing children in China, which were, however, more pronounced among children with autism.
    Journal of Nutritional Science. 01/2013; 2.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Attention-deficit/hyperactivity disorder (ADHD) can be viewed as the extreme end of traits in the general population. Epidemiological and twin studies suggest that ADHD frequently co-occurs with and shares genetic susceptibility with autism spectrum disorder (ASD) and ASD-related traits. The aims of this study were to determine whether a composite of common molecular genetic variants, previously found to be associated with clinically diagnosed ADHD, predicts ADHD and ASD-related traits in the general population. Polygenic risk scores were calculated in the Avon Longitudinal Study of Parents and Children (ALSPAC) population sample (N = 8229) based on a discovery case-control genome-wide association study of childhood ADHD. Regression analyses were used to assess whether polygenic scores predicted ADHD traits and ASD-related measures (pragmatic language abilities and social cognition) in the ALSPAC sample. Polygenic scores were also compared in boys and girls endorsing any (rating ≥1) ADHD item (n = 3623). Polygenic risk for ADHD showed a positive association with ADHD traits (hyperactive-impulsive, p = .0039; inattentive, p = .037). Polygenic risk for ADHD was also negatively associated with pragmatic language abilities (p = .037) but not with social cognition (p = .43). In children with a rating ≥1 for ADHD traits, girls had a higher polygenic score than boys (p = .003). These findings provide molecular genetic evidence that risk alleles for the categorical disorder of ADHD influence hyperactive-impulsive and attentional traits in the general population. The results further suggest that common genetic variation that contributes to ADHD diagnosis may also influence ASD-related traits, which at their extreme are a characteristic feature of ASD.
    Biological psychiatry 02/2014; · 8.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper extensively and comprehensively reviews the literature on epidemiology of autism focusing on the prevalence rates of Autistic Disorder (AD) and Autism Spectrum Disorder (ASD), and the potential negative impact of DSM-5 ASD on future ASD prevalence studies. Between 1966 and 2013, there are 72 published prevalence studies of AD and 61 published studies of ASD. The AD has a broad range of prevalence rates and has shown a trend of increasing rates over time. But there are also some evidences showing that the increase seems to have leveled off. The current prevalence of AD is estimated in the range of 10–30 per 10,000 people (i.e., 1 in 1000 to 1 in 333). The ASD also has a wide range of prevalence rates with a median rate of 69.5 per 10,000 people (1 in 144). When the prevalence rates are subdivided into several sub-ranges (e.g., 10–20, 20–40, etc. per 10,000), it is difficult to pick a particular sub-range to represent the prevalence of ASD. The present review notes that several recent studies comparing the utility of DSM-IV/DSM-IV-TR ASD and the DSM-5 ASD have reported that about 9–54% of DSM-IV ASD cases do not qualify for the DSM-5 ASD. Suggestions of research designs for future ASD prevalence studies are offered.
    Research in Autism Spectrum Disorders 11/2014; 8(11):1454–1470. · 2.96 Impact Factor

Preview

Download
0 Downloads